Georgetown University home page Search: Full text search Site Index: Find a web site by name or keyword Site Map: Overview of main pages Directory: Find a person; contact us About this site: Copyright, disclaimer, policies, terms of use Georgetown University home page Home page for prospective students Home page for current students Home page for alumni and alumnae Home page for family and friends Home page for faculty and staff Georgetown University Search: Full text search Site Index: Find a web site by name or keyword Site Map: Overview of main pages Directory: Find a person; contact us About this site: Copyright, disclaimer, policies, terms of use
Navigation bar Navigation bar
spacer spacer spacer spacer
border
spacer spacer spacer
border
spacer spacer

FOR IMMEDIATE RELEASE: October 1, 2012


CONTACT:

Karen Mallet
(media only)
km463@georgetown.edu


Georgetown University Medical Center Establishes Center for Drug Discovery


WASHINGTON – Georgetown University Medical Center announces the establishment of the Center for Drug Discovery under the inaugural direction of Milton L. Brown, M.D., Ph.D., an associate professor of oncology and a member of Georgetown Lombardi Comprehensive Cancer Center.

The Center for Drug Discovery (CDD) comprises members from various disciplines to collaborate in drug discovery and in the development of a pipeline for molecular targets. The Center will offer a full continuum from drug discovery through pre-clinical studies and clinical trials. In this regard, specialized teams will be formed to bring together medicinal chemists, biologists, scientists and physicians toward a common goal of discovery, and development of new interventions in areas of unmet need in cancer, neurological, cardiovascular and infectious diseases.

“Academic drug discovery is an emerging and much needed area for advancing human health,” explains Brown. “The CDD will help create a model academic center to actively support faculty and collaborators in providing innovative therapies for improving the care of patients.”

Initiatives include education, innovative and transformative research, collaborative programs, and embedded translational expertise, he adds.

The CDD is a translational medicine initiative made possible by the award of a Chemical Diversity Center grant from the National Cancer Institute (NCI) and membership in the NCI Chemical Biology Consortium.

“Georgetown University Medical Center has a long history of distinguished leadership in drug discovery and development,” says Howard J. Federoff, M.D., Ph.D., executive vice president for health sciences at GUMC and executive dean of Georgetown’s School of Medicine. “The CDD will build on these strengths functioning as a vertically integrated research Center within GUMC that will interact with the existing research and clinical capabilities in the discovery and development of novel therapeutics in meeting its goal of multi-disciplinary research and education.”

In addition to serving as the Center’s director, Brown is principal investigator of the NCI Chemical Diversity Center grant. He holds the Edwin H. Richard and Elisabeth Richard von Matsch Endowed Chair in Experimental Therapeutics at Georgetown and is associate professor in the Department of Oncology. A national and international leader in academic drug discovery and development, Brown has filed new patents on novel compounds to treat cancer, epilepsy, pain, chronic kidney disease, hypertension, and radiation sensitizing and protective agents.

About Georgetown Lombardi Comprehensive Cancer Center
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, and the only one in the Washington, DC, area. For more information, go to http://lombardi.georgetown.edu.

About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing & Health Studies, both nationally ranked; Georgetown Lombardi Comprehensive Cancer Center, designated as a comprehensive cancer center by the National Cancer Institute; and the Biomedical Graduate Research Organization (BGRO), which accounts for the majority of externally funded research at GUMC including a Clinical Translation and Science Award from the National Institutes of Health. In fiscal year 2010-11, GUMC accounted for 85 percent of the university’s sponsored research funding.


###






spacer spacer
Navigation bar Navigation bar